Schuler Education Foundation's Form 4 filing
Biolase, Inc (BIOL) · filed May 26, 2023
- Accession no.
- 0000908834-23-000047
- Filed
- May 26, 2023, 1:13 PM ET
- Trade date
- Feb 11-Dec 18, 2020
- Filing delay
- 1,200 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 12 non-derivative transactions and 3 derivative transactions. Open-market purchases total $797.8K. Open-market sales total $4.14M. It was filed 1200 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuler Education FoundationCIK 0001512977 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2020 | Common Stock | PPurchaseAcquired | +1,307,931 | $0.61 | +$797,837.91 | 10,936,444 | Direct | |
| Jun 8, 2020 | Common Stock | SSaleDisposed | −1,847,649 | $0.55F2 | −$1,016,206.95 | 9,088,795 | Direct | |
| Jun 9, 2020 | Common Stock | SSaleDisposed | −2,137,559 | $0.54F3 | −$1,154,281.86 | 6,951,236 | Direct | |
| Jun 10, 2020 | Common Stock | SSaleDisposed | −1,733,836 | $0.55F4 | −$953,609.8 | 5,217,400 | Direct | |
| Jul 28, 2020 | Common Stock | CConversionAcquired | +3,745,000 | $0.40 | +$1,498,000 | 8,962,400 | Direct | |
| Nov 24, 2020 | Common Stock | SSaleDisposed | −71,100 | $0.30 | −$21,330 | 8,891,300 | Direct | |
| Nov 25, 2020 | Common Stock | SSaleDisposed | −203,057 | $0.29 | −$58,886.53 | 8,688,243 | Direct | |
| Nov 30, 2020 | Common Stock | SSaleDisposed | −1,115,000 | $0.30 | −$334,500 | 7,573,243 | Direct | |
| Dec 4, 2020 | Common Stock | SSaleDisposed | −1,200,000 | $0.30 | −$360,000 | 6,373,243 | Direct | |
| Dec 16, 2020 | Common Stock | SSaleDisposed | −90,575 | $0.28 | −$25,361 | 6,282,668 | Direct | |
| Dec 17, 2020 | Common Stock | SSaleDisposed | −572,671 | $0.28 | −$160,347.88 | 5,709,997 | Direct | |
| Dec 18, 2020 | Common Stock | SSaleDisposed | −187,774 | $0.28 | −$52,576.72 | 5,522,223 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2020 | Common Stock | AGrant or awardAcquired | +3,745,000 | –F5 | – | 1,498 | Direct | |
| Jul 22, 2020 | Common Stock | AGrant or awardAcquired | +3,745,000 | –F5 | – | 3,745,000 | Direct | |
| Jul 28, 2020 | Common Stock | CConversionDisposed | −3,745,000 | –F7 | – | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5399 and $0.5643, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5430 and $0.5601, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The sale price reported is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $0.5485 and $0.5656, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
In connection with a public offering by the Issuer, on July 22, 2020, the Reporting Person acquired (i) 1,498 shares of Series F Convertible Preferred Stock, each of which is convertible into 2,500 shares of Common Stock, for a total of up to 3,745,000 shares of Common Stock, and (ii) 3,745,000 Warrants, each of which is exercisable to purchase one share of Common Stock, for a total of up to 3,745,000 shares of Common Stock, for an aggregate purchase price of $1,500,000.
Referenced by the price of 2 transactions in Table II.
- F7
On July 28, 2020, the Reporting Person converted 1,498 shares of Series F Convertible Preferred Stock into 3,745,000 shares of Common Stock.
Referenced by the price of 1 transaction in Table II.